Investigation of SARS-CoV-2 infection and associated lesions in exotic and companion animals.
COVID-19
bronchopneumonia
cats
dogs
respiratory
severe acute respiratory syndrome coronavirus 2
syncytial cell
tiger
viral
zoonosis
Journal
Veterinary pathology
ISSN: 1544-2217
Titre abrégé: Vet Pathol
Pays: United States
ID NLM: 0312020
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
pubmed:
19
1
2022
medline:
22
6
2022
entrez:
18
1
2022
Statut:
ppublish
Résumé
Documented natural infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in exotic and companion animals following human exposures are uncommon. Those documented in animals are typically mild and self-limiting, and infected animals have only infrequently died or been euthanized. Through a coordinated One Health initiative, necropsies were conducted on 5 animals from different premises that were exposed to humans with laboratory-confirmed SARS-CoV-2 infection. The combination of epidemiologic evidence of exposure and confirmatory real-time reverse transcriptase-polymerase chain reaction testing confirmed infection in 3 cats and a tiger. A dog was a suspect case based on epidemiologic evidence of exposure but tested negative for SARS-CoV-2. Four animals had respiratory clinical signs that developed 2 to 12 days after exposure. The dog had bronchointerstitial pneumonia and the tiger had bronchopneumonia; both had syncytial-like cells with no detection of SARS-CoV-2. Individual findings in the 3 cats included metastatic mammary carcinoma, congenital renal disease, and myocardial disease. Based on the necropsy findings and a standardized algorithm, SARS-CoV-2 infection was not considered the cause of death in any of the cases. Continued surveillance and necropsy examination of animals with fatal outcomes will further our understanding of natural SARS-CoV-2 infection in animals and the potential role of the virus in development of lesions.
Identifiants
pubmed: 35038930
doi: 10.1177/03009858211067467
pmc: PMC9207983
doi:
Types de publication
Journal Article
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
707-711Subventions
Organisme : FDA HHS
ID : U18 FD006161
Pays : United States
Organisme : FDA HHS
ID : U18 FD006173
Pays : United States
Organisme : FDA HHS
ID : U18 FD006379
Pays : United States
Références
EBioMedicine. 2020 Nov;61:103104
pubmed: 33158808
Science. 2021 Jan 8;371(6525):172-177
pubmed: 33172935
Viruses. 2021 Sep 12;13(9):
pubmed: 34578394
Nature. 2020 Oct;586(7831):776-778
pubmed: 32408337
J Am Vet Med Assoc. 2021 Nov 1;259(9):1032-1039
pubmed: 34647475
Pathogens. 2020 Jun 30;9(7):
pubmed: 32629960
MMWR Morb Mortal Wkly Rep. 2020 Jun 12;69(23):710-713
pubmed: 32525853
Emerg Microbes Infect. 2020 Dec;9(1):2322-2332
pubmed: 33028154
mBio. 2020 Oct 13;11(5):
pubmed: 33051368
J Infect Dis. 2021 Mar 3;223(5):752-764
pubmed: 33502471
Emerg Infect Dis. 2020 Aug;26(8):
pubmed: 32396505
Vet Rec. 2021 Apr;188(8):e247
pubmed: 33890314
Br J Pharmacol. 2020 Nov;177(21):4851-4865
pubmed: 32462701
Vet Res. 2021 Feb 15;52(1):22
pubmed: 33588935
Arch Pathol Lab Med. 2021 Jul 1;145(7):785-796
pubmed: 33720333
Emerg Infect Dis. 2020 Sep;26(9):2005-2015
pubmed: 32437316
Vet Pathol. 2020 Sep;57(5):653-657
pubmed: 32663073